GSK Investigational Site

Terni, Umbria 05100

0 studies enrolling now · 4 studies all time

What they study most

Arthritis, Rheumatoid, Cancer, Nausea and Vomiting, Chemotherapy-Induced, Sarcoma, Soft Tissue

Studies at this site

• A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. — Completed
• A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma — Completed
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
• Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy — Completed